
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Undisclosed
Therapeutic Area : Oncology
Study Phase : Discovery Platform
Sponsor : Eureka Therapeutics
Deal Size : Undisclosed
Deal Type : Collaboration
Porton Advanced, Eureka Collaborate to Accelerate T-Cell Therapy
Details : The collaboration aims to leverage proprietary ARTEMIS cell receptor and E‑ALPHA antibody discovery platforms to drive innovation in safer, more effective T‑cell therapies.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
March 19, 2025
Lead Product(s) : Undisclosed
Therapeutic Area : Oncology
Highest Development Status : Discovery Platform
Sponsor : Eureka Therapeutics
Deal Size : Undisclosed
Deal Type : Collaboration
